Teledermatology: Remote Skin Assessment and Diagnosis
Teledermatology applies remote communication technology to the evaluation, diagnosis, and management of skin conditions — without requiring a patient to sit in a waiting room. This page covers how that process works in practice, the clinical scenarios where it fits best, and the situations where it doesn't. Understanding those boundaries matters because dermatology has an unusually high referral backlog: the American Academy of Dermatology has noted wait times of 30 to 60 days or more in underserved areas, a gap that teledermatology is specifically positioned to address.
Definition and scope
Teledermatology is a subspecialty of telehealth that uses digital imaging, video, and structured clinical data to perform dermatological assessment at a distance. It sits within the broader telehealth types and modalities framework, but it has a defining technical characteristic that sets it apart from most other telehealth specialties: the primary diagnostic input is a visual image, not a conversation.
That distinction matters more than it might seem. A psychiatrist doing a video visit is essentially replicating an in-office interaction. A dermatologist reviewing a high-resolution image of a suspicious lesion is doing something structurally different — working from a captured artifact rather than a live examination. The entire specialty pivots on image quality, standardization, and the clinical protocols built around both.
The scope of teledermatology covers:
- Diagnostic consultations — evaluating rashes, lesions, pigmented spots, inflammatory skin disease, and other visible conditions from submitted images or live video
- Triage decisions — determining urgency of an in-person visit or biopsy
- Chronic disease management — monitoring conditions like psoriasis, eczema (atopic dermatitis), or rosacea over time without requiring every follow-up to be in-person
- Second opinions — specialist review of images already captured by a primary care provider or referring clinician
How it works
Two distinct delivery models define teledermatology in clinical practice, and they are not interchangeable.
Store-and-forward (asynchronous) is the more common model. A patient or referring provider captures standardized digital images — typically under specific lighting conditions with required angles for lesions — and submits them through a secure platform along with a clinical history. The dermatologist reviews the case on their own schedule, often within 24 to 72 hours, and returns a documented assessment. No live interaction occurs. This model is detailed further at store-and-forward telehealth.
Live interactive (synchronous) uses real-time video between patient and dermatologist. It resembles a standard telehealth visit but remains limited for dermatology because consumer-grade cameras frequently lack the resolution to capture dermatoscopic detail reliably. Live visits work better for follow-up discussions, treatment adjustments, and patient education than for initial lesion assessment.
A hybrid approach pairs store-and-forward imaging with a brief live video segment — useful when a clinician wants to ask follow-up questions after reviewing submitted images.
Image standardization is the operational backbone of the entire system. The National Telehealth Authority tracks clinical standards across telehealth specialties; for dermatology specifically, the American Telemedicine Association has published image capture guidelines that address resolution minimums, lighting requirements, and scale reference markers for lesion photography.
Common scenarios
Teledermatology performs well across a specific and well-documented range of presentations:
- Acne — Severity scoring, medication adjustment, and isotretinoin monitoring (with appropriate lab confirmation) are well-suited to image-based review
- Atopic dermatitis and psoriasis — Established patients with known diagnoses benefit from remote flare assessment without repeated travel
- Tinea and fungal infections — Classic presentations are often visually diagnostic with adequate imaging
- Contact dermatitis — History-taking combined with image review frequently yields accurate attribution
- Pigmented lesion screening — Particularly valuable in rural and underserved populations (telehealth for rural communities) where dermatologist access is sparse
- Post-procedure follow-up — Wound healing assessment after biopsies or excisions
A 2019 study published in JAMA Dermatology found diagnostic concordance between teledermatology and in-person assessment at rates exceeding 80% for common inflammatory conditions — a figure that climbs when image capture protocols are followed rigorously.
Decision boundaries
Teledermatology has real clinical limits, and the honest accounting of those limits is what makes the modality trustworthy rather than overpromised.
Conditions that generally require in-person evaluation:
- Any lesion where malignancy cannot be excluded without dermoscopy performed with calibrated equipment
- Suspected melanoma or high-risk pigmented lesions — remote imaging is useful for screening but insufficient for a definitive diagnosis without biopsy
- Bullous diseases (pemphigus, pemphigoid) requiring skin biopsy for confirmation
- Widespread or rapidly evolving eruptions suggesting serious systemic involvement — erythroderma, Stevens-Johnson syndrome, or toxic epidermal necrolysis demand immediate in-person or emergency evaluation
- Conditions requiring palpation, such as assessment of skin texture, subcutaneous nodules, or lymphadenopathy
The contrast with in-person care is structural, not merely logistical — explored in more depth at telehealth vs in-person care. Teledermatology excels at pattern recognition from a distance; it cannot replicate touch, real-time dermoscopy with a handheld device, or the clinical gestalt a provider develops from being physically present.
Reimbursement coverage adds another layer of variability. Medicare telehealth rules and state-specific Medicaid policies govern whether store-and-forward teledermatology is a covered service, and coverage is not uniform across all jurisdictions — telehealth policy and regulation tracks those distinctions. California and Hawaii have historically been among the states with the most explicit store-and-forward parity provisions, while other states limit coverage to live-interactive modalities only.